Business
Annual Report and Notice of Annual General Meeting
Annual Report and Notice of Annual General Meeting.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n\n \n3 June 2025\nAdvanced Medical Solutions Group plc\n(\"AMS\", the \"Company\" or the \"Group\")\n \nAnnual Report and Notice of Annual General Meeting\n \nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, is pleased to announce that its Annual Report and Accounts for the year ended 31 December 2024 and Notice of Annual General Meeting (\"AGM\") have today been sent to shareholders.\n \nThe Annual Report and Accounts is available on the Investor Relations section of the Company's website https://admedsol.com/Investor-Relations.\n \nThe AGM will be held at 11:00 a.m. at the offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QN on 30 June 2025.\n \nA copy of the proxy form for the AGM and Notice of AGM are available on the Company's website https://admedsol.com/investor-relations/shareholder-information/agm.\n \n- End -\n \nFor further information, please visit www.admedsol.com or contact:\n \n\n\n\n\nAdvanced Medical Solutions Group plc\n\n\nTel: +44 (0) 1606 545508\n\n\n\n\nChris Meredith, Chief Executive Officer\nEddie Johnson, Chief Financial Officer\nMichael King, Investor Relations\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\nICR Healthcare\n\n\nTel: +44 (0) 20 3709 5700\n\n\n\n\nMary-Jane Elliott / Lucy Featherstone\n\n\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n\nInvestec Bank PLC (NOMAD & Joint Broker)\n\n\nTel: +44 (0) 20 7597 5970\n\n\n\n\nGary Clarence / David Anderson\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBerenberg (Joint Broker) \n\n\nTel: +44 (0)20 3207 7800\n\n\n\n\nToby Flaux / Detlir Elezi / Yasmina Benchekroun\n \n\n\n\n\n\n\n\n \nAbout Advanced Medical Solutions Group plc - see www.admedsol.com\nAMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, LIQUIFIX™, Peters Surgical, Ifabond, Vitalitec and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its Act...